ArticleMalawi medical journal : the journal of Medical Association of Malawi2026
Utility of Bronchoalveolar Lavage Fluid Cellular Composition in the Differential Diagnosis of Idiopathic Pulmonary Fibrosis: a preliminary study.
Article in Malawi medical journal : the journal of Medical Association of Malawi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease with poor prognosis. Its early diagnosis is challenging due to nonspecific clinical features and overlap with infectious pulmonary diseases. Bronchoalveolar lavage fluid (BALF) provides direct access to lower respiratory tract cellular components, offering potential adjunctive diagnostic value. This study aimed to evaluate the cytological characteristics of BALF in IPF and assess their utility in differentiating IPF from non-fibrotic pneumonia. Methods: We retrospectively analyzed 64 IPF patients and 64 age-, sex-, and intensive care unit (ICU) admission-matched patients with community-acquired pneumonia (CAP) who underwent BAL at the First Affiliated Hospital of Xi'an Jiaotong University (January 2021-November 2025). BALF total cell counts and differential cell proportions were measured. Multivariable logistic regression identified independent discriminators, and receiver operating characteristic (ROC) curve analysis evaluated the diagnostic performance of individual and combined BALF parameters. Results: IPF patients showed significantly higher proportions of macrophages (median 29.55% vs. 11.70%, P<0.001), lymphocytes (7.20% vs. 3.60%, P=0.031), and eosinophils (1.00% vs. 0.40%, P=0.008), and a significantly lower neutrophil proportion (58.50% vs. 80.90%, P<0.001) compared with pneumonia patients. Multivariable analysis confirmed eosinophil percentage (OR=1.871, 95%CI:1.123-2.836) and macrophage percentage (OR=1.139, 95%CI:1.082-1.199) as independent discriminators of IPF. The combined logistic regression model incorporating these two parameters yielded an area under the curve (AUC) of 0.832 (95%CI:0.761-0.903), with a sensitivity of 93.8% and a specificity of 65.6%, outperforming either parameter alone. Conclusions: BALF cellular profiles differ significantly between IPF and non-fibrotic pneumonia. Macrophage and eosinophil percentages are independent discriminators of IPF, and their combination provides good discriminative performance. Although BALF cytology alone is insufficient for a definitive diagnosis, it serves as a valuable adjunctive tool, particularly when high-resolution computed tomography findings are atypical or when infection is suspected. These findings support the potential utility of BALF cellular analysis in the diagnostic workup of IPF and warrant further prospective validation, including integration with molecular biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.